- Home
- ATHA vs TOMZ Comparison
ATHA vs TOMZ Comparison
Compare ATHA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- TOMZ
- Stock Information
- Founded
- ATHA 2011
- TOMZ 1979
- Country
- ATHA United States
- TOMZ United States
- Employees
- ATHA N/A
- TOMZ N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- TOMZ Diversified Commercial Services
- Sector
- ATHA Health Care
- TOMZ Finance
- Exchange
- ATHA Nasdaq
- TOMZ Nasdaq
- Market Cap
- ATHA 21.0M
- TOMZ 20.2M
- IPO Year
- ATHA 2020
- TOMZ N/A
- Fundamental
- Price
- ATHA $0.30
- TOMZ $0.80
- Analyst Decision
- ATHA Buy
- TOMZ Strong Buy
- Analyst Count
- ATHA 4
- TOMZ 1
- Target Price
- ATHA $11.25
- TOMZ $3.50
- AVG Volume (30 Days)
- ATHA 206.7K
- TOMZ 28.8K
- Earning Date
- ATHA 05-14-2025
- TOMZ 04-14-2025
- Dividend Yield
- ATHA N/A
- TOMZ N/A
- EPS Growth
- ATHA N/A
- TOMZ N/A
- EPS
- ATHA N/A
- TOMZ N/A
- Revenue
- ATHA N/A
- TOMZ $7,738,842.00
- Revenue This Year
- ATHA N/A
- TOMZ $84.25
- Revenue Next Year
- ATHA N/A
- TOMZ $64.23
- P/E Ratio
- ATHA N/A
- TOMZ N/A
- Revenue Growth
- ATHA N/A
- TOMZ 5.22
- 52 Week Low
- ATHA $0.22
- TOMZ $0.53
- 52 Week High
- ATHA $3.67
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- ATHA 49.02
- TOMZ 51.02
- Support Level
- ATHA $0.22
- TOMZ $0.72
- Resistance Level
- ATHA $0.30
- TOMZ $0.83
- Average True Range (ATR)
- ATHA 0.03
- TOMZ 0.06
- MACD
- ATHA 0.01
- TOMZ 0.01
- Stochastic Oscillator
- ATHA 79.22
- TOMZ 85.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.